COMBINING IMMUNOTHERAPY AND MYC SYNTHETIC LETHALITY FOR METASTATIC BREAST CANCER

$2,000,000FY2021Defense Health AgencyDOD

Helsingin Yliopisto

Investigators

View source on USAspending →